ESVS Guidelines: Section A--prevention in patients with carotid stenosis

Curr Vasc Pharmacol. 2010 Sep;8(5):673-81. doi: 10.2174/157016110792006905.

Abstract

Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Antihypertensive Agents / therapeutic use
  • Carotid Stenosis / blood
  • Carotid Stenosis / drug therapy*
  • Carotid Stenosis / physiopathology*
  • Carotid Stenosis / therapy
  • Cerebrovascular Disorders / blood
  • Cerebrovascular Disorders / epidemiology*
  • Cerebrovascular Disorders / prevention & control*
  • Cerebrovascular Disorders / therapy
  • Cholesterol, LDL
  • Contraindications
  • Drug Monitoring
  • Drug Therapy, Combination / adverse effects
  • Humans
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / therapeutic use
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Risk Factors

Substances

  • Antihypertensive Agents
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Platelet Aggregation Inhibitors